Home > Animal Health & Nutrition > Veterinary Medical Devices > Veterinary Injectable Devices Market

Veterinary Injectable Devices Market Size

Report ID: GMI6053
Published Date: Jun 2023
Report Format: PDF

Download Free Sample

Veterinary Injectable Devices Market Size

Veterinary Injectable Devices Market size was valued at USD 879.1 million in 2022 and is expected to reach USD 1.4 billion by 2032, growing at a CAGR of over 4.9% driven by increasing demand for veterinary healthcare, technological developments in veterinary medicine such as safety features, autoinjectors, & needle technology, and the need for disease prevention and management.

To get key market trends

Download Free Sample

Furthermore, advances in veterinary medicine and technology have had a significant impact on the industry. The development of innovative injectable devices with improved features, such as precision dosing, ease of administration, and reduced pain. These advancements enhance treatment efficacy, improve patient comfort, and streamline the delivery of injectable medications.

Veterinary Injectable Devices Market Report Attributes
Report Attribute	Details
Base Year:	2022
Veterinary Injectable Devices Market Size in 2022:	USD 879.1 Million
Forecast Period:	2023 to 2032
Forecast Period 2023 to 2032 CAGR:	4.9%
2032 Value Projection:	USD 1.4 Billion
Historical Data for:	2018 to 2022
No. of Pages:	251
Tables, Charts & Figures:	434
Segments covered:	Product, Material, Usage, Animal type, End-user, and Region
Growth Drivers:	Rising pet ownership Growing awareness about animal health in pet owners Increasing prevalence of animal diseases Increasing animal medicalization rate
Pitfalls & Challenges:	Injuries and infections caused by needles Increasing use of alternative delivery methods

Learn more about the key segments shaping this market

Download Free Sample

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market for veterinary injectable devices was worth USD 879.1 million in 2022 and is expected to reach USD 1,418.3 million by 2032 driven by the increasing demand for veterinary healthcare and the rising need for disease prevention and management.

The syringes product segment held 29.3% share in the market and is estimated to depict significant growth through 2032 owing to the rising trend of pet ownership and the growing awareness of animal health.

North America industry is poised to grow at 4.7% CAGR from 2023 to 2032 attributed to the presence of well-developed veterinary infrastructure, including veterinary practices, hospitals, and clinics across the region.

Merck & Co., Inc., Hamilton Company, Neogen Corporation, Micrel Medical Devices SA, Serumwerk Bernburg AG, PBS Animal Health, Medtronic plc, Millpledge Pharmaceuticals, Terumo Medical Corporation, and Baxter International Inc. are among the top participants in the industry.